OakChart

Cencora Inc

CORHealthcare·Medical Distribution·USA·Large·NYSE·Nov 11 • 10:08 AM ET

346.87-1.84 (-0.53%)
2026-11-11 16:08 CET
Market cap
66,543.28 USD m
Revenue, TTM
337,397.30 USD m
Net income, TTM
3,483.90 USD m
Free cash flow, TTM
3,880.67 USD m
EPS diluted, TTM
17.91
P/E
19.36
Compare

Price

COR against its 20, 50 and 200-day averages
2050200beatmiss
250.00300.00350.001.7M3.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CORclose 346.8720-day 338.1850-day 326.41200-day 316.67346.87

8.1% under 377.54 on 25 Nov 2025. Last 15 sessions, 13.7% high to low

Profile

COR
52-week range, 77% of the way up
244.82377.54

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

IndexS&P 500, RUI
Employees51000
IPOApr 04, 1995
Beta0.57
ATR, 14d9.01
Rel volume0.34
Short float1.66%
Insider own0.46%
Inst own99.13%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap66.19B
Enterprise Value72.77B
Income3.48B
Sales337.40B
Book/sh15.99
Cash/sh25.57
Dividend Est.2.41 (0.69%)
Dividend TTM2.40 (0.69%)
Dividend Ex-DateNov 13, 2026
Dividend Gr. 3/5Y7.35% 6.40%
Payout13.37%
Employees51000
IPOApr 04, 1995

Ratios

P/E19.36
Forward P/E15.94
PEG1.47
P/S0.20
P/B21.70
P/C13.56
P/FCF17.06
EV/EBITDA12.61
EV/Sales0.22
Quick Ratio0.57
Current Ratio0.94
Debt/Eq3.06
LT Debt/Eq3.01
Option/ShortYes / Yes

Earnings

EPS (ttm)17.91
EPS next Y21.76
EPS next Q4.56
EPS this Y9.71%
EPS next Y10.37%
EPS next 5Y10.86%
EPS past 3/5Y28.14% 19.43%
Sales past 3/5Y8.77% 9.53%
EPS Y/Y TTM124.34%
Sales Y/Y TTM5.00%
EPS Q/Q254.68%
Sales Q/Q5.52%
EarningsNov 04 BMO
EPS/Sales Surpr.1.73% 0.46%

Ownership

Insider Own0.46%
Insider Trans-0.79%
Inst Own99.13%
Inst Trans-2.45%
ROA4.26%
ROE134.27%
ROIC23.63%
Gross Margin3.79%
Oper. Margin1.40%
Profit Margin1.03%
SMA202.57%
SMA506.27%
SMA2009.54%
Trades-

Technical

Shs Outstand190.83M
Shs Float189.94M
Short Float1.66%
Short Ratio2.41
Short Interest3.16M
52W High377.54 -8.12%
52W Low244.82 41.68%
Volatility4.13% 2.47%
ATR (14)9.01
RSI (14)59.22
Beta0.57
Rel Volume0.34
Avg Volume1.31M
Volume62,633

Performance

Perf Week-2.01%
Perf Month5.08%
Perf Quarter11.89%
Perf Half Y35.67%
Perf YTD2.70%
Perf Year-4.99%
Perf 3Y75.57%
Perf 5Y175.97%
Perf 10Y339.52%
Recom1.89
Target Price383.92
Prev Close348.71
Price346.87
Change %-0.53%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 19, 2026InitiatedRRBC Capital MktsSector Perform$330-4.9%
Apr 28, 2026InitiatedWWilliam BlairMkt Perform
Jan 29, 2026UpgradeMMorgan StanleyEqual-Weight → Overweight$400+15.3%
Jan 22, 2026UpgradeJJefferiesHold → Buy$440+26.8%
Dec 09, 2025InitiatedBBarclaysOverweight$400+15.3%
Jun 03, 2025UpgradeWWells FargoEqual Weight → Overweight$337-2.8%
Dec 04, 2024ResumedMMizuhoOutperform$280-19.3%
Sep 18, 2024DowngradeBBofA SecuritiesBuy → Neutral$275 → $245-29.4%
Feb 26, 2024InitiatedLLeerink PartnersOutperform$261-24.8%
Jan 03, 2024InitiatedBBarclaysOverweight$242-30.2%

Peers

Mkt cap
TickerCompanyMkt cap
CAHCardinal Health Inc63.95B
MCKMckesson Corp123.85B
HSICHenry Schein Inc9.68B
CVSCVS Health Corp112.82B
MDLNMedline Inc55.20B
CICigna Group77.62B
UNHUnitedhealth Group Inc356.63B
ELVElevance Health Inc91.32B
HUMHumana Inc53.14B
OPCHOption Care Health Inc4.74B

Insider trading

latest 14 of 43
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Mauch Robert P.President & CEONov 06 '26Option Exercise0.004,066069,459Nov 10 03:55 PM
Campbell Elizabeth SExecutive Vice PresidentNov 06 '26Option Exercise0.001,830021,285Nov 10 03:54 PM
Krikorian LazarusSVP & Chief Accounting OfficerNov 06 '26Option Exercise0.001,398015,595Nov 10 03:53 PM
Verma PawanEVP, Chief Data & Info OfficerOct 30 '26Option Exercise0.008,538013,686Nov 03 04:11 PM
Krikorian LazarusSVP & Chief Accounting OfficerNov 02 '26Sale330.96986326,32714,197Nov 03 04:07 PM
Krikorian LazarusSVP & Chief Accounting OfficerOct 01 '26Sale303.18986298,93515,183Oct 05 03:59 PM
GREENBERG LON RDirectorSep 16 '26Sale321.301,280411,26417,128Sep 17 03:58 PM
Lon GreenbergDirectorSep 16 '26Proposed Sale321.311,280411,282Sep 16 11:37 AM
Battaglia SilvanaFormer OfficerSep 11 '26Proposed Sale325.001,324430,300Sep 11 12:09 PM
Cleary James FFormer OfficerSep 04 '26Proposed Sale335.1710,0003,351,656Sep 04 12:03 PM
Krikorian LazarusSVP & Chief Accounting OfficerSep 01 '26Sale325.97985321,08016,169Sep 02 04:00 PM
Battaglia SilvanaFormer OfficerSep 01 '26Proposed Sale330.006,5932,175,690Sep 01 02:13 PM
Campbell Elizabeth SExecutive Vice PresidentAug 24 '26Sale324.1211,3003,662,66319,455Aug 25 04:14 PM
Campbell Elizabeth SOfficerAug 24 '26Proposed Sale324.1011,3013,662,663Aug 24 01:31 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
IWPiShares Russell Mid-Cap Growth ETFAUM: 18.09B
VOEVanguard Morningstar Mid-Cap Value ETFAUM: 24.66B
VIGVanguard Dividend Appreciation FTFAUM: 117.07B

News

latest 14 of 206
  • Cencora Closes FY26 Above Raised Guidance, But A Divestiture-Diluted FY27 Outlook Resets Expectations Lower (Earnings Whispers)
  • Cencora: Fiscal Q4 Earnings Snapshot (Associated Press)
  • Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results (Business Wire)
  • Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus (Business Wire)
  • Cencora's Fiscal Year-End Report Tests Whether Its US Operating Rebound Has Staying Power (Earnings Whispers)
  • Loading…
  • Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology (Business Wire)
  • Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release (Business Wire)
  • Cencora Elects Robert E. Sanchez to Its Board of Directors (Business Wire)
  • Cencora Tech Chief: AI Is Cutting Some Medical Treatment Decisions in Half (WSJ)
  • The Realities of Managing Enterprise AI (WSJ)
  • Cencora Inc. stock underperforms Wednesday when compared to competitors (MarketWatch) -5.90%
  • S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results (Investor's Business Daily)
  • Cencora Inc (COR) (Q3 2026) Earnings Call Highlights: Strong Double-Digit Growth and Raised Guidance (GuruFocus.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q42026-11-044.6604.5812.71088,35587,95114
2026Q32026-08-054.4804.3473.93784,75584,31514
2026Q22026-05-064.7504.8188.40178,35681,08814
2026Q12026-02-044.0804.0492.86585,93286,05916
2025Q42025-11-053.8403.787-1.75283,72983,45815
2025Q32025-08-064.0003.8483.52180,66480,09515
2025Q22025-05-074.4204.1153.68075,50075,68015
2025Q12025-02-053.7303.5022.50381,48778,31115
2024Q42024-11-063.3403.2270.01779,05077,61916
2024Q32024-07-313.3403.2172.41774,24173,32016
2024Q22024-05-013.8003.6942.09268,40070,59616
2024Q12024-01-313.2802.8962.98072,25369,25415
2023Q42023-11-022.8602.8071.72468,92266,25213
2023Q32023-08-022.9202.8192.34766,94763,93114
2023Q22023-05-023.5003.2972.13263,45760,45915
2023Q12023-02-012.7102.6382.32562,84762,81213

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY7.0907.0494.038179,589179,180
2020FY7.9007.867-16.646189,894188,715
2021FY9.2609.2317.387213,989212,196
2022FY11.03011.0028.043238,587237,879
2023FY11.99011.9328.531262,173259,669
2024FY13.76013.6507.535293,959292,539
2025FY16.00015.9387.961321,333321,049
2026FY17.97017.89217.950337,397337,019
2027FY-19.714--352,653
2028FY-21.758--369,019
2029FY-24.485--384,813
2030FY-28.345--398,523

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q1S2026-11-0982090,29589,52791,079
2027Q1S2026-11-0572090,34989,52791,079
2027Q1S2026-11-0462090,35289,52791,079
2027Q1S2026-10-2750090,00489,11890,602
2027Q1S2026-10-2150190,00489,11890,602
2027Q1S2026-10-2051190,00489,11890,602
2027Q1S2026-10-1551190,00489,11890,602
2027Q1S2026-10-0961189,74688,45790,602
2027Q1S2026-10-0661189,77088,45790,602
2027Q1S2026-10-0551189,60488,45790,481
2027Q1S2026-08-1851189,60488,45790,481
2027Q1S2026-08-1341189,43288,45790,481
2027Q1S2026-08-0741089,75888,45791,784
2027Q1S2026-08-0540189,37187,99991,784

Estimate history

EPS, annual7.534.038-16.6467.3878.0438.5317.5357.96117.95
Period201820192020202120222023202420252026
EPS, quarterly0.0172.5033.683.521-1.7522.8658.4013.9372.71
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Sales, annual167939.635179589.121189893.926213988.843238587.006262173.411293958.599321332.819337397.299
Period201820192020202120222023202420252026
Sales, quarterly79050.10681487.0675453.67380663.53283728.55485932.01678355.91684754.83788354.53
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Shares, annual213.218206.761204.226208.089206.204200.815194.944193.938-190.826
Period201820192020202120222023202420252026MRQ
Shares, quarterly194.944193.849193.784193.861193.938194.522194.561190.826-
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue337,397.30337,397.30321,332.82293,958.60262,173.41238,587.01213,988.84189,893.93179,589.12
Cost of Goods Sold Incl. D&A324,608.75324,574.57311,191.30285,257.36254,416.91230,986.37207,719.58185,102.18175,059.09
Gross Profit12,788.5512,822.7310,141.528,701.247,756.507,600.646,269.264,791.754,530.03
Selling, General and Administrative Excl. Other8,078.228,078.226,493.845,661.115,309.984,848.963,594.252,767.222,663.51
Other Operating Expense--0.000.000.000.000.000.000.00
Operating Income4,710.334,744.513,647.683,040.132,446.512,751.682,675.012,024.531,866.53
Interest Expense538.51489.86419.75248.68275.65231.98182.54158.52195.47
Unusual Expense769.76814.451,054.59827.00105.54380.46270.097,182.06754.60
Net Income Before Taxes4,580.814,580.812,258.342,003.972,160.842,183.062,221.86-5,293.83967.11
Income Taxes1,079.391,079.39690.52484.70428.26516.52677.25-1,894.27112.97
Consolidated Net Income3,501.423,501.421,567.811,519.271,732.581,666.541,544.61-3,399.56854.13
Net Income From Continuing Operations3,483.903,483.901,554.171,509.121,745.291,698.821,539.93-3,408.72855.37
Net Income3,483.903,483.901,554.171,509.121,745.291,698.821,539.93-3,408.72855.37
EPS (Recurring)--11.7410.438.899.308.297.906.53
EPS (Basic, Before Extraordinaries)17.9918.038.027.608.628.157.48-16.654.07
EPS (Diluted)17.9117.957.967.538.538.047.39-16.654.04
EBITDA5,770.345,789.954,705.924,151.813,418.913,449.623,180.182,426.152,355.07
Non-Operating Income (Expense)1,130.111,140.6185.0039.5295.5143.83-0.5122.2250.66
Other After Tax Adjustments--0.000.000.000.000.000.000.00
Stock Option Compensation Expense--116.89116.9298.4573.7972.7054.3242.98
Price To Earnings Ratio19.4719.4732.1524.4321.9416.8416.17-20.42
Price To Sales Ratio0.170.170.190.150.140.120.120.100.10
Gross Margin3.793.803.162.962.963.192.932.522.52
Operating Margin1.401.411.141.030.931.151.251.071.04
Net Margin1.031.030.480.510.670.710.72-1.800.48
Shares Outstanding--193.94194.94200.81206.20208.09204.23206.76
Market Capitalization66,543.2866,543.2860,592.6944,351.3436,147.6928,048.2324,820.1619,785.4417,151.48

Income statement, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q32025Q22025Q1
Total Revenue88,354.5384,754.8478,355.9285,932.0283,728.5580,663.5375,453.6781,487.06
Cost of Goods Sold Incl. D&A85,020.2581,422.6075,033.4183,132.5081,125.0978,005.1372,837.8579,223.23
Gross Profit3,334.283,332.243,322.512,799.522,603.472,658.402,615.822,263.83
Selling, General and Administrative Excl. Other2,172.912,132.471,977.561,795.291,748.871,672.881,600.041,472.06
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income1,161.371,199.781,344.951,004.23854.60985.521,015.78791.78
Interest Expense136.29154.52154.3493.36109.36116.90132.3261.18
Unusual Expense254.5779.56202.36233.28938.58103.09-34.8878.37
Net Income Before Taxes787.21996.392,088.57708.64-187.04896.28928.66620.45
Income Taxes258.11219.73459.04142.51146.03206.53211.24126.73
Consolidated Net Income529.10776.671,629.53566.13-333.07689.75717.42493.72
Net Income From Continuing Operations519.40763.521,641.33559.65-339.70687.40717.87488.60
Net Income519.40763.521,641.33559.65-339.70687.40717.87488.60
EPS (Recurring)-4.229.133.701.643.893.552.78
EPS (Basic, Before Extraordinaries)2.723.958.442.88-1.753.553.702.52
EPS (Diluted)2.713.948.402.87-1.753.523.682.50
EBITDA1,427.621,472.731,604.411,265.591,115.611,241.741,277.381,071.18
Non-Operating Income (Expense)16.6930.701,100.3231.056.29130.7410.30-31.78
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense-22.7022.1252.1820.4917.5222.4855.60
Price To Earnings Ratio19.4721.7137.7842.4732.1534.8039.5729.94
Price To Sales Ratio0.170.160.190.200.190.180.170.14
Gross Margin3.773.934.243.263.113.303.472.78
Operating Margin1.311.421.721.171.021.221.350.97
Net Margin0.590.902.090.65-0.410.850.950.60
Shares Outstanding-190.83194.56194.52193.94193.86193.78193.85
Market Capitalization66,543.2855,056.8761,109.9765,521.1460,592.6958,117.8353,926.3843,426.15

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments4,880.344,394.553,231.242,689.773,533.172,547.144,597.753,374.192,492.52
Short Term Receivables26,334.2925,225.3023,960.0420,988.2018,625.2418,389.0514,334.7312,386.8811,314.23
Inventories22,639.9920,492.4818,998.8318,769.6217,088.4616,639.9113,933.9312,207.7411,918.51
Other Current Assets4,596.952,126.741,527.69351.23342.891,226.51189.30163.24169.12
Total Current Assets58,451.5652,239.0747,717.8142,798.8339,589.7638,802.6133,055.7028,132.0525,894.37
Net Property, Plant & Equipment3,039.044,087.553,323.033,154.543,079.983,230.141,928.331,770.521,892.42
Total Investments and Advances-0.0066.6463.1260.370.000.000.000.00
Intangible Assets22,456.3517,450.7013,319.0714,005.9012,836.6214,287.468,592.839,000.349,612.10
Deferred Tax Assets24.56208.81246.35200.67237.57290.79361.64287.64348.30
Other Assets3,133.462,603.972,428.762,335.70756.32726.81336.33269.07270.94
Total Assets87,104.9876,590.1167,101.6762,558.7556,560.6257,337.8144,274.8339,459.6238,018.14
Short Term Debt Incl. Current Port. of LT Debt203.21371.56781.10823.811,228.66475.56593.85139.01151.66
Accounts Payable58,011.4054,719.7650,942.1645,836.0440,192.8938,009.9531,705.0628,385.0726,836.87
Other Current Liabilities4,166.282,729.222,553.792,171.362,056.412,873.121,554.181,057.21881.16
Total Current Liabilities62,380.8957,820.5454,277.0548,831.2043,477.9641,358.6433,853.0829,581.2927,869.69
Long Term Debt11,062.948,959.624,841.725,070.365,496.657,329.874,003.774,354.404,510.83
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities1,759.691,620.721,643.751,657.941,620.411,685.30686.492,147.832,177.71
Other Liabilities8,220.216,442.145,552.406,332.965,894.336,379.596,571.14382.89409.95
Total Liabilities83,423.7474,843.0366,314.9361,892.4656,489.3456,753.3945,114.4736,466.4134,968.18
Non-Equity Reserves-0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity3,681.241,508.02645.94522.00-211.56223.35-1,018.922,878.922,932.82
Total Shareholders Equity3,681.241,508.02645.94522.00-211.56223.35-1,018.922,878.922,932.82
Accumulated Minority Interest-239.07140.80144.28282.83361.06179.29114.29117.14
Total Equity3,681.241,747.09786.74666.2971.27584.41-839.642,993.213,049.96
Total Liabilities & Stockholders Equity87,104.9876,590.1167,101.6762,558.7556,560.6257,337.8144,274.8339,459.6238,018.14
Book Value Per Share-7.783.312.60-1.031.07-4.9913.9213.76
Tangible Book Value Per Share--82.21-65.01-67.15-63.28-67.59-47.06-29.61-31.33
Full-Time Employees-51,00046,00046,00044,00042,00022,00022,00021,000
Price to Book Ratio21.8130.6047.9353.02-131.90111.29-19.435.916.46
Return on Assets4.262.162.332.932.983.03-8.142.214.52
Return on Equity134.27144.31258.421,124.3928,805.77--366.5329.4466.37
Return on Invested Capital23.6314.8527.5031.2132.1420.39-114.2011.8322.28
Quick Ratio0.570.550.530.490.520.540.560.540.50
Current Ratio0.940.900.880.880.910.940.980.950.93

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income7,002.847,002.841,567.811,519.271,732.581,666.541,535.26-3,399.56854.13
Depreciation--1,058.241,111.67972.39697.94505.06401.62488.54
Other Funds (Non Cash)-2,897.78-2,897.781,153.77657.37450.69282.08-75.92480.92603.61
Funds from Operations4,105.064,105.063,839.703,186.003,036.792,842.752,299.26-4,061.991,974.83
Extraordinary Item--0.000.000.000.000.000.000.00
Changes in Working Capital685.11685.1135.42298.69874.54-139.66367.326,269.03369.20
Income Taxes Payable-----196.15-330.08-54.88-3.29-13.35
Cash from Operating Activities4,790.174,790.173,875.123,484.683,911.332,703.092,666.592,207.042,344.02
Capital Expenditures-909.50-909.50-667.98-487.17-458.36-496.32-438.22-369.68-310.22
Net Assets From Acquisitions-4,994.58-4,994.58-4,095.63-69.77-1,409.84-133.81-5,563.040.00-63.95
Sale of Fixed Assets and Businesses--0.000.000.00278.8914.4436.360.00
Purchase or Sale of Investments-39.43-39.43-196.24-30.43-743.27-18.49-162.62-56.080.00
Purchase of Investments-39.43-39.43-196.24-30.43-743.27-18.49-162.62-56.080.00
Sale Or Maturity of Investments--0.000.000.000.000.000.000.00
Other Uses---34.81-50.000.000.000.000.00-1.66
Other Sources142.91142.9117.3719.289.001.307.869.520.00
Cash from Investing Activities-5,800.60-5,800.60-4,977.29-618.10-2,602.47-368.44-6,141.58-379.87-375.83
Cash Dividends Paid-476.81-476.81-437.08-416.17-398.75-391.69-366.65-343.58-338.97
Change in Capital Stock-1,000.05-1,000.05-406.34-1,453.53-1,119.58-389.79116.60-194.56-597.80
Repurchase of Common Pref Stock-1,000.05-1,000.05-435.47-1,491.37-1,180.73-483.70-82.15-420.45-674.03
Sale of Common Pref Stock--29.1337.8461.1593.91198.75225.8976.23
Proceedsfrom Stock Options--0.000.000.000.000.0066.360.00
Issuance or Reduction of Debt, Net3,248.493,248.493,195.67-385.45-623.26-923.102,216.55-32.01-133.07
Change in Long Term Debt3,248.493,248.493,195.67-385.45-623.26-923.102,216.55-32.01-133.07
Issuance of Long Term Debt3,248.493,248.49136,642.7170,391.3778,375.994,987.798,135.80716.431,147.07
Reduction of Long Term Debt---133,447.04-70,776.82-78,999.24-5,910.90-5,919.24-748.43-1,280.15
Net Financing Active Other Cash Flow-118.50-118.50-103.14-75.85-80.69-48.20-13.65-33.47-16.67
Other Financing Activities Uses-118.50-118.50-103.14-75.85-80.69-48.20-23.55-33.47-16.67
Cash from Financing Activities1,653.131,653.132,249.11-2,330.99-2,222.28-1,752.781,952.85-603.62-1,086.51
Exchange Rate Effect-46.49-46.49-50.279.4072.76-57.85-3.73--
Net Change in Cash596.21596.211,096.67544.99-840.65524.02-1,525.871,223.55881.68
Free Cash Flow3,880.673,880.673,207.142,997.513,452.972,206.772,228.371,837.362,033.80
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Price to Free Cash Flow16.9117.1222.0217.4612.0615.7513.3813.2910.29
Deferred Taxes & Investment Tax Credit--59.86-102.32-118.86196.18334.87-1,544.9728.54

Balance sheet, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Cash & Short Term Investments4,880.342,864.962,236.261,808.694,394.552,275.33
Short Term Receivables26,334.2925,448.1024,893.2225,979.9225,225.3024,561.73
Inventories22,639.9921,030.3420,010.0124,078.4920,492.4820,137.85
Other Current Assets4,596.955,991.736,001.422,284.472,126.741,839.25
Total Current Assets58,451.5655,335.1453,140.9154,151.5852,239.0748,814.16
Net Property, Plant & Equipment3,039.042,838.222,805.422,450.804,087.552,431.38
Total Investments and Advances-0.000.000.000.000.00
Intangible Assets22,456.3522,446.1822,507.3817,409.4917,450.7018,255.11
Deferred Tax Assets24.56179.42192.82206.82208.81228.29
Other Assets3,133.463,006.603,005.564,142.532,603.974,227.97
Total Assets87,104.9883,805.5581,652.1078,361.2176,590.1173,956.90
Short Term Debt Incl. Current Port. of LT Debt203.21279.15202.66342.28371.56196.79
Accounts Payable58,011.4054,699.7951,881.8256,063.8254,719.7651,043.87
Other Current Liabilities4,166.284,218.164,047.812,726.042,729.222,717.37
Total Current Liabilities62,380.8959,197.1056,132.2959,132.1457,820.5453,958.03
Long Term Debt11,062.9411,444.0912,182.867,579.468,959.628,043.70
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities1,759.691,785.871,748.181,635.671,620.721,614.72
Other Liabilities8,220.218,139.418,003.837,917.986,442.148,130.56
Total Liabilities83,423.7480,566.4678,067.1576,265.2574,843.0371,747.01
Non-Equity Reserves-0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3,681.243,050.963,397.591,908.331,508.021,980.19
Total Shareholders Equity3,681.243,050.963,397.591,908.331,508.021,980.19
Accumulated Minority Interest-188.13187.36187.64239.07229.70
Total Equity3,681.243,239.093,584.952,095.971,747.092,209.89
Total Liabilities & Stockholders Equity87,104.9883,805.5581,652.1078,361.2176,590.1173,956.90
Book Value Per Share-15.9917.469.817.7810.21
Tangible Book Value Per Share--101.64-98.22-79.69-82.21-83.95
Full-Time Employees----51,000-
Price to Book Ratio21.8116.2032.0243.4430.6057.37
Return on Assets4.263.333.332.202.162.70
Return on Equity134.27104.34115.58152.25144.31130.60
Return on Invested Capital3.525.2710.535.90-3.256.86
Quick Ratio0.570.580.590.510.550.53
Current Ratio0.940.930.950.920.900.90

Cash flow, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Net Income4,030.52776.671,629.53566.13-333.07689.75
Depreciation-272.95259.46261.36261.01256.22
Other Funds (Non Cash)-1,937.72-2.25-1,210.00252.18919.00-18.57
Funds from Operations1,051.381,102.26857.391,094.03902.33910.74
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital2,051.261,551.81481.25-3,399.202,231.09-801.50
Cash from Operating Activities3,102.642,654.061,338.64-2,305.173,133.42109.25
Capital Expenditures-398.47-226.04-165.62-119.38-249.81-183.22
Net Assets From Acquisitions-20.89-41.66-4,712.35-219.69-91.41-56.46
Sale of Fixed Assets and Businesses-27.040.7243.060.000.00
Purchase or Sale of Investments-10.96-9.27-8.50-10.71-2.45-1.22
Purchase of Investments-10.96-9.27-8.50-10.71-2.45-1.22
Sale Or Maturity of Investments-0.000.000.000.000.00
Other Uses-2.38-2.380.004.366.20
Other Sources114.897.4013.237.4017.370.00
Cash from Investing Activities-386.24-240.15-4,874.90-299.31-321.94-234.69
Cash Dividends Paid-116.25-116.59-117.46-126.52-107.51-107.49
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Change in Capital Stock0.00-1,000.05-7.607.606.526.83
Repurchase of Common Pref Stock0.00-1,000.050.000.000.000.00
Sale of Common Pref Stock-0.00-7.607.606.526.83
Proceedsfrom Stock Options-0.000.000.000.000.00
Issuance or Reduction of Debt, Net-85,327.88-648.214,111.55266.21-582.24322.40
Change in Long Term Debt-85,327.88-648.214,111.55266.21-582.24322.40
Issuance of Long Term Debt-85,327.8812,923.6251,753.4423,899.3145,980.7943,709.52
Reduction of Long Term Debt--13,571.82-47,641.89-23,633.10-46,563.03-43,387.11
Net Financing Active Other Cash Flow-3.50-2.98-7.93-104.09-0.55-6.26
Other Financing Activities Uses-3.50-2.98-7.93-104.09-0.55-6.26
Cash from Financing Activities-600.82-1,767.833,978.5743.20-683.78215.48
Exchange Rate Effect-20.97-10.699.75-24.58-8.476.72
Net Change in Cash2,094.61635.39452.06-2,585.862,119.2296.76
Free Cash Flow2,704.172,428.021,173.02-2,424.552,883.61-73.97
Price to Free Cash Flow16.9115.2855.8420.9121.8882.33

Revenue breakdown

United States2025: 321.33B
Consolidation, Policy2025: -15.53M
International Healthcare Solutions2025: 30.37B
U.S. Healthcare Solutions2025: 290.98B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.66%3.2M189.9M1.31M
2026-10-152.07%3.9M189.9M1.32M
2026-09-302.06%3.9M190.0M1.38M
2026-09-152.27%4.3M190.0M1.45M
2026-08-312.38%4.5M189.9M1.46M
2026-08-142.45%4.6M189.9M1.61M
2026-07-312.72%5.2M189.9M1.77M
2026-07-153.03%5.9M193.6M1.82M
2026-06-302.84%5.5M193.6M1.77M
2026-06-153.23%6.2M193.3M1.78M
2026-05-292.85%5.5M193.6M1.75M
2026-05-152.73%5.3M193.6M1.62M
2026-04-302.68%5.2M193.7M1.40M
2026-04-152.50%4.8M193.8M1.35M
2026-03-312.66%5.2M193.8M1.34M
2026-03-132.54%4.9M193.8M1.19M
2026-02-272.45%4.8M193.8M1.31M
2026-02-132.77%5.4M193.8M1.41M
2026-01-302.29%4.4M193.7M1.42M
2026-01-152.52%4.9M193.8M1.40M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call125220.2223.5221.53.4371.000.000.987-0.3440.019
call130214.7218.60.003.3180.000.000.986-0.3440.019
call135209.7213.60.003.1990.000.000.986-0.3430.020
call140204.6208.60.003.0840.000.000.985-0.3420.020
call145199.7203.60.002.9730.000.000.984-0.3420.021
call150194.9198.60.003.0090.000.000.984-0.3410.022
call155189.6193.60.002.7630.000.000.983-0.3400.023
call160184.6188.6160.62.6631.000.000.983-0.3390.023
call165179.6183.61612.5661.000.000.982-0.3380.024
call170174.7178.60.002.4720.000.000.981-0.3360.025
call175169.7173.60.002.6550.000.000.981-0.3350.026
call180164.9168.61412.4121.000.000.980-0.3340.026
call185159.7163.60.002.4650.000.000.979-0.3320.027
call190154.9158.6134.12.1232.000.000.978-0.3310.028
call195149.7153.682.002.0411.000.000.978-0.3290.029
call200144.8148.60.002.1970.000.000.977-0.3270.030
call210134.6138.6114.51.8072.000.000.975-0.3240.032
call220124.6128.697.401.6601.000.000.973-0.3200.034
call230115118.695.101.6071.000.000.970-0.3150.037
call240104.8108.6101.051.3831.000.000.968-0.3110.039
call25094.6098.7026.901.2737.000.000.965-0.3050.043
call26084.7088.7028.001.1446.000.000.961-0.2990.046
call27074.7078.7052.491.0191.000.000.957-0.2920.050
call28065.0068.7082.200.9403.000.000.951-0.2830.055
call29055.3058.3056.680.7121370.000.945-0.2740.061
call30044.9048.7042.280.66017.000.000.936-0.2630.068
call31035.4038.5039.530.6132420.000.923-0.2470.079
call32025.7028.9028.910.5161920.000.897-0.2470.098
call33016.7020.0020.950.3991170.000.769-0.4540.167
call3409.0012.5012.500.4091580.000.632-0.4680.206
call3503.006.706.250.3562520.000.468-0.4760.218
call3600.603.701.720.3982080.000.286-0.4220.186
call3700.052.751.150.4703050.000.200-0.4020.153
call3800.002.402.370.5423240.000.161-0.4050.134
call3900.002.251.400.6263120.000.133-0.4090.118
call4000.002.150.300.70034.000.000.112-0.4060.105
call4100.002.150.400.80144.000.000.107-0.4490.101
call4200.002.150.900.88422.000.000.099-0.4680.096
call4300.002.150.000.8770.000.000.070-0.3550.073
call4400.002.150.000.9470.000.000.065-0.3650.070
call4500.002.150.001.0360.000.000.068-0.4120.072
call4600.002.150.001.1030.000.000.065-0.4220.069
call4700.002.150.001.2260.000.000.072-0.5090.075
put1250.002.150.003.3010.000.00-0.013-0.3370.019
put1300.002.150.003.1840.000.00-0.014-0.3350.019
put1350.002.100.003.0770.000.00-0.014-0.3350.020
put1400.002.100.002.9680.000.00-0.015-0.3330.020
put1450.002.100.002.8610.000.00-0.015-0.3320.021
put1500.002.150.002.7550.000.00-0.016-0.3300.022
put1550.002.150.002.6580.000.00-0.017-0.3290.023
put1600.002.150.452.5633.000.00-0.017-0.3270.023
put1650.002.150.352.4732.000.00-0.018-0.3260.024
put1700.002.150.502.3826.000.00-0.018-0.3240.025
put1750.002.150.752.2951.000.00-0.019-0.3220.026
put1800.002.150.002.2110.000.00-0.020-0.3200.026
put1850.002.150.002.1290.000.00-0.021-0.3180.027
put1900.002.150.102.04912.000.00-0.021-0.3160.028
put1950.002.152.701.9711.000.00-0.022-0.3140.029
put2000.002.150.011.8952.000.00-0.023-0.3120.030
put2100.002.150.051.7484.000.00-0.025-0.3070.032
put2200.002.150.401.60716.000.00-0.027-0.3020.034
put2300.002.150.401.47826.000.00-0.029-0.2970.037
put2400.002.150.951.34112.000.00-0.032-0.2900.040
put2500.002.151.701.2219.000.00-0.035-0.2840.042
put2600.002.150.421.09741.000.00-0.039-0.2770.046
put2700.002.150.600.97516.000.00-0.043-0.2680.050
put2800.002.150.020.85280.000.00-0.049-0.2580.055
put2900.001.751.800.74471.000.00-0.055-0.2480.061
put3000.002.300.490.6321510.00-0.064-0.2360.068
put3100.052.500.370.5104060.00-0.077-0.2190.079
put3200.351.000.680.4057170.00-0.097-0.2090.094
put3300.404.001.760.4805320.00-0.243-0.4360.171
put3402.955.503.750.40540.000.00-0.351-0.4290.203
put3507.1010.307.630.4074.000.00-0.538-0.4400.218
put36013.6017.5020.800.4471.000.00-0.701-0.3990.190
put37022.4026.3031.700.5261.000.00-0.790-0.3790.158
put38032.0036.000.000.6060.000.00-0.840-0.3700.133
put39041.8045.700.000.6470.000.00-0.866-0.3800.118
put40051.9055.700.000.8000.000.00-0.883-0.3910.108
put41061.9065.601060.8980.000.00-0.893-0.4110.101
put42071.8075.900.000.9870.000.00-0.901-0.4280.096
put43081.8085.80101.51.0620.000.00-0.907-0.4440.091
put44091.8095.9095.301.1431.000.00-0.912-0.4580.087
put450101.8105.8117.031.2200.000.00-0.917-0.4700.084
put460111.8115.92051.3040.000.00-0.921-0.4820.081
put470121.8125.70.001.3860.000.00-0.924-0.4920.078

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-218-KCurrent report2026-10-21SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-258-KCurrent report2026-09-24SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-16144Filing for proposed sale of securities under Rule 144.SEC
2026-09-11144Filing for proposed sale of securities under Rule 144.SEC
2026-09-04144Filing for proposed sale of securities under Rule 144.SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-24144Filing for proposed sale of securities under Rule 144.SEC
2026-08-148-KCurrent report2026-08-13SEC
2026-08-128-KCurrent report2026-08-12SEC
2026-08-06144Filing for proposed sale of securities under Rule 144.SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-08-058-KCurrent report2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100326.33K1
2026-1000298.94K1
2026-0900732.34K2
2026-08003.66M1
2026-070000
2026-061.25M200
2026-051.07M100
2026-040000
2026-030000
2026-02001.83M2
2026-01001.81M1
2025-12004.86M4
2025-11001.87M1

Institutional holders

Manager% owned
BlackRock, Inc.9.36%
VANGUARD CAPITAL MANAGEMENT LLC6.36%
VANGUARD PORTFOLIO MANAGEMENT LLC4.94%
STATE STREET CORP4.77%
T. Rowe Price Investment Management, Inc.3.81%
PRICE T ROWE ASSOCIATES INC /MD/3.67%
JPMORGAN CHASE & CO3.05%
GEODE CAPITAL MANAGEMENT, LLC2.85%
Boston Partners2.75%
WELLINGTON MANAGEMENT GROUP LLP2.34%

Funds

Fund% owned
JPMorgan Core Bond Fund16.09%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND15.42%
DFA Investment Grade Portfolio14.85%
PGIM Short-Term Corporate Bond Fund9.02%
First Trust Limited Duration Investment Grade Corporate ETF7.97%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND7.75%
VANGUARD INSTITUTIONAL INTERMEDIATE-TERM BOND FUND7.71%
Baird Aggregate Bond Fund7.71%
VANGUARD INSTITUTIONAL SHORT-TERM BOND FUND6.33%
JPMorgan Ultra-Short Income ETF5.37%

OakChart. COR. Cached 15 minutes.